TESSA (Tracking-Enabled Spatial Surgery Assistant) uses accelerated computing and AI technology to deliver personalized planning, augmented reality, advanced imaging, navigation and real-time tracking capabilities. The company aims for its platform to help transform arthroscopic procedures.

London-based Smith+Nephew submitted TESSA to the FDA last year. It sees the “spatial surgery” platform as a way to deliver personalized planning, augmented reality and real-time data processing into platforms that interpret the surgical field intraoperatively. The technology originally came out of Perceive3D, a spin-off from the University of Coimbra that Smith+Nephew acquired.